ISSN: 2278-0238

International Journal of Research and Development in Pharmacy & Life Sciences
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

RECENT DEVELOPMENTS ON ANTI-CONVULSANTS

Abstract

Epilepsy is not a disease, but a syndrome of different cerebral disorders of the CNS. This syndrome is characterized by paroxysmal, excessive, and hypersynchronous discharges of large numbers of neurons. The first major division of epilepsy is localization-related (i.e., focal, local, partial) epilepsies, which account for about 60% of all epilepsies. The remainder, about 40%, is composed of generalized epilepsies. The most common, and most difficult to treat, seizures in Adult patients are complex partial seizures, whereas primary generalized tonic-clonic (formerly, “Grand mal" epilepsy) seizures respond in most patients to treatment with anticonvulsants. Thus a need for new drugs with a greater benefit as related to side effects and tolerability, even at the expense of efficacy, when compared to the existing antiepileptic agents.

Keywords

Top